Antibe Therapeutics is Drug Discovery in Canada that focus on Antibe Therapeutics Inc business. Founded in 2004. They cover business area such as Antibe Therapeutics Inc, out-license, new pharmaceutical, its main objective, its lead compound otenaproxesul, prospective global partner, two segment, Citagenix, its revenue, distributor, regenerative medicine, brand biologic, medical device, bone regeneration, Canada, Europe.
2004
( 22 years old in 2026 )
Antibe Therapeutics Inc
-
15 Prince Arthur Avenue
Toronto, Ontario M5R 1B2
Canada
Private
Antibe Therapeutics Incout-licensenew pharmaceuticalits main objectiveits lead compound otenaproxesulprospective global partnertwo segmentCitagenixits revenuedistributorregenerative medicinebrand biologicmedical devicebone regenerationCanadaEurope
* We use standard office opening hours in near Antibe Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Antibe Therapeutics is Drug Discovery business from Canada that founded in 2004 (22 years old in 2026), Antibe Therapeutics business is focusing on Antibe Therapeutics Inc.
Antibe Therapeutics headquarter office and corporate office address is located in 15 Prince Arthur Avenue Toronto, Ontario M5R 1B2 Canada.
Antibe Therapeutics was founded in Canada.
In 2026, Antibe Therapeutics is currently focus on Antibe Therapeutics Inc sector.
Above is snippet of Google Trends for "Antibe Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Antibe Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
